Literature DB >> 16633845

Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood.

M E Atabek1, O Pirgon, S Kurtoglu, H Imamoglu.   

Abstract

Acute phase proteins have been suggested to be increased in patients with type 1 diabetes. The aim of this study was to evaluate the relationship between serum C-reactive protein (CRP) and intima-media thickness (IMT) and functions of the common carotid artery (CCA) in children and adolescents with type 1 diabetes. Serum CRP levels were measured in 65 children and adolescents with diabetes (33 girls and 32 boys; mean age, 12.7 +/- 3.8 years; range, 7-18; duration of diabetes, 6.9 +/- 3.6 years). Age and diabetes duration, as well as major cardiovascular risk factors including anthropometric and metabolic parameters, were matched between girls and boys. The relations of serum CRP levels to CCA structure and functions were measured by ultrasonography as IMT, cross-sectional compliance, cross-sectional distensibility, diastolic wall stress (DWS), and incremental elastic modulus (IEM). There was no significant difference for serum CRP levels between girls and boys (3.7 +/- 1.3 vs 3.2 +/- 0.4 mg/L; p > 0.05). CRP was positively correlated with IMT (r = 0.49, p = 0.001), IEM (r = 0.24, p = 0.05), DWS (r = 0.58, p < 0.001), and body mass index (BMI) (r = 0.28, p = 0.05). In a multivariate regression model, we included CRP and metabolic and anthropometric parameters such as duration of diabetes, HbA1c, BMI, waist:hip ratio, age, and systolic and diastolic blood pressure as independent variables in the model for CCA structure and functions. CRP emerged as an independent correlation for mean IMT (beta = 0.51, p < 0.001) and DWS (beta = 0.61, p < 0.001). According to our findings, CRP was associated with CCA structure and functions in children and adolescents with type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633845     DOI: 10.1007/s00246-006-1199-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

Review 1.  Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists.

Authors:  F Dati; G Schumann; L Thomas; F Aguzzi; S Baudner; J Bienvenu; O Blaabjerg; S Blirup-Jensen; A Carlström; P H Petersen; A M Johnson; A Milford-Ward; R F Ritchie; P J Svendsen; J Whicher
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-06

2.  Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation.

Authors:  C G Schalkwijk; D C Poland; W van Dijk; A Kok; J J Emeis; A M Dräger; A Doni; V W van Hinsbergh; C D Stehouwer
Journal:  Diabetologia       Date:  1999-03       Impact factor: 10.122

3.  Coronary artery calcification in older adults to age 99: prevalence and risk factors.

Authors:  A B Newman; B L Naydeck; K Sutton-Tyrrell; A Feldman; D Edmundowicz; L H Kuller
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

4.  Mechanical properties of the common carotid artery in Williams syndrome.

Authors:  Y Aggoun; D Sidi; B I Levy; S Lyonnet; J Kachaner; D Bonnet
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

5.  Arterial mechanical changes in children with familial hypercholesterolemia.

Authors:  Y Aggoun; D Bonnet; D Sidi; J P Girardet; E Brucker; M Polak; M E Safar; B I Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

6.  C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis.

Authors:  M E Hunt; P G O'Malley; M N Vernalis; I M Feuerstein; A J Taylor
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

7.  Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.

Authors:  Rieko Hayaishi-Okano; Yoshimitsu Yamasaki; Naoto Katakami; Kentaro Ohtoshi; Shin-Ichi Gorogawa; Akio Kuroda; Munehide Matsuhisa; Keisuke Kosugi; Norikiyo Nishikawa; Yoshitaka Kajimoto; Masatsugu Hori
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

Review 8.  C-reactive protein: a novel marker of cardiovascular risk.

Authors:  Svati H Shah; L Kristin Newby
Journal:  Cardiol Rev       Date:  2003 Jul-Aug       Impact factor: 2.644

9.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification.

Authors:  Helen M Colhoun; Casper Schalkwijk; Michael B Rubens; Coen D A Stehouwer
Journal:  Diabetes Care       Date:  2002-10       Impact factor: 19.112

View more
  9 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

2.  Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function.

Authors:  Elaine M Urbina; Thomas R Kimball; Connie E McCoy; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan
Journal:  Circulation       Date:  2009-05-26       Impact factor: 29.690

3.  Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes.

Authors:  Carlo Palombo; Michaela Kozakova; Carmela Morizzo; Laura Gnesi; Maria Chiara Barsotti; Paolo Spontoni; Francesco Massart; Paolo Salvi; Alberto Balbarini; Giuseppe Saggese; Rossella Di Stefano; Giovanni Federico
Journal:  Cardiovasc Diabetol       Date:  2011-10-08       Impact factor: 9.951

4.  Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.

Authors:  Mehmet Emre Atabek; Yusuf Özkul; Beray Selver Eklioğlu; Selim Kurtoğlu; Murat Baykara
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-03

5.  Approach to lipid screening as a risk marker for cardiovascular disease in pediatric patients with diabetes.

Authors:  Jennifer Rachel Law; Shipra Patel; Anna Spagnoli
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-11       Impact factor: 5.555

6.  Serum adiponectin and hsCRP levels and non-invasive radiological methods in the early diagnosis of cardiovascular system complications in children and adolescents with type 1 diabetes mellitus.

Authors:  Damla Gökşen; Ertürk Levent; Sakine Kar; Samim Ozen; Sükran Darcan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013-09-10

7.  HLA, infections and inflammation in early stages of atherosclerosis in children with type 1 diabetes.

Authors:  Michal Odermarsky; Erkki Pesonen; Timo Sorsa; Åke Lernmark; Pirkko J Pussinen; Petru Liuba
Journal:  Acta Diabetol       Date:  2017-10-24       Impact factor: 4.280

8.  Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT).

Authors: 
Journal:  BMC Pediatr       Date:  2009-12-17       Impact factor: 2.125

9.  Two-Dimensional Speckle Tracking Versus Applanation Tonometry in Evaluation of Subclinical Atherosclerosis in Children with Type 1 Diabetes Mellitus.

Authors:  Michał Podgórski; Katarzyna Szatko; Małgorzata Stańczyk; Monika Pawlak-Bratkowska; Michał Fila; Ewa Bieniek; Marcin Tkaczyk; Piotr Grzelak; Maciej Łukaszewski
Journal:  Med Sci Monit       Date:  2019-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.